MicroRNA Molecule May Serve as Biomarker
Monday, February 18, 2013
MicroRNA molecule called miR-7 decreased in highly metastatic cancer stem-like cells.
Gene Thought to be Linked to Alzheimer's is Marker for Only Mild Impairment
Monday, February 18, 2013
Defying the widely held belief that a specific gene is the biggest risk factor for Alzheimer's disease, report says that people with that gene are more likely to develop mild cognitive impairment -- but not Alzheimer's.
Insight Genetics Promotes Four
Wednesday, February 13, 2013
Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.
Horizon Wins Most Promising Company at World Conference on Personalized Medicine
Tuesday, February 12, 2013
Award based on technology, performance to date, and forward plans.
The WIN Consortium and New York University Cancer Institute Collaborate
Tuesday, February 12, 2013
The Worldwide Innovative Network (WIN) in personalized cancer medicine Consortium is proud to announce that New York University Cancer Institute has joined as a member of the Consortium.
4SC Discovery Receives Research Grant of EUR 600,000
Monday, February 11, 2013
Munich m4 biotech cluster programme supports research collaboration with the Medical Clinic of the University of Munich on preclinical development of novel compounds for cancer immunotherapy.
Cellmid Signs Midkine Diagnostic Agreement
Monday, February 11, 2013
Multiple cancer diagnostic products are expected to be developed.
Study Finds Potential to Match Tumors with Known Cancer Drugs
Friday, February 08, 2013
Mapping the landscape of kinases could aid in new world of personalized cancer treatment.
Scientists Find Way to Knockup Genes
Thursday, February 07, 2013
Italian scientists use molecular RNA Chaperones to increase protein production from individual genes.
|
|
|
|
|
|
